(b) If the executive commissioner establishes a plan under this subchapter, the commissioner shall publish a report not afterwards than January one of every odd-numbered 12 months around the medical effectiveness of the usage of tetrahydrocannabinols and their derivatives and another clinical results from the research program.(one) failure to refil